LFA Funding Opportunities for Lupus Investigators (Request for Applications)
LFA's 2013 Requests for Applications (RFAs)
Applications are now being accepted for four new RFAs for LFA's 2013 National Research Program:
- Career Development Award (download application guidelines here) (no Letter of Intent required)
- Advancement of Research on Stem Cells in Lupus (download application guidelines here for RFA 013-01 S)
- Neuropsychiatric Lupus (download application guidelines here for RFA 013-02 NP)
- Pediatric Lupus: Quality of Life (download application guidelines here for RFA 013-04 P)
Letter of Intent deadline has been extended to March 1, 2013
- Awards in the amounts of $120,000
- Duration of award: One year
- Letter of Intent deadline: March 1, 2013 at 5 p.m. ET
- Application deadline: March 22, 2013 at 5 p.m. ET
- Notification date: September 27, 2013
Applicants are encouraged to register and complete a professional profile at proposalCENTRAL as soon as possible. Applicants should ensure that their grants and contracts office has registered their institutional, financial, and signing officials with proposalCENTRAL.
LFA uses an electronic grants submission process. All interested grant applicants must submit their full application packages through proposalCENTRAL at the following webpage: https://proposalcentral.altum.com/. A proposalCENTRAL helpline is available for questions from applicants, Monday – Friday, 8:30 a.m. – 5:30 p.m., EST. Customer support is available via phone at 1-800-875-2562 or by email at email@example.com.
Bringing Down the Barriers™
Our national research program, Bringing Down the Barriers™, is dedicated to addressing gaps in lupus research and other obstacles that have obstructed basic, clinical, epidemiological, behavioral, and translational lupus research for decades.
The Foundation's prestigious peer-reviewed grant program follows the high standards set by the National Institutes of Health and is guided by LFA’s Medical-Scientific Advisory Council.
Since its inception, the Lupus Foundation of America and its national network of chapters have provided $23 million to support more than 400 grants to research scientists at nearly 100 leading academic and medical institutions throughout the nation. The Foundation in recent years also has generated an additional $40 million in government funding for specific lupus research studies through its ongoing advocacy efforts. We also have worked with the biotech and pharmaceutical industries, private foundations, and other organizations, to stimulate additional investment in lupus research and drug development.
We are proud and honored to have provided seed grants to many of the world’s leading lupus researchers. These grants have not only led to tens of millions of dollars in additional research funding, but have also significantly facilitated many of the lupus-related scientific breakthroughs of the last 30 years.
For over 20 years, investigators that we funded have published in such prestigious peer-reviewed journals as Science, Nature, Proceedings of the National Academy of Sciences, Immunity, and Genes and Immunity.
We focus our support in areas of research where significant gaps in scientific knowledge about lupus exist, and where other public and private organizations are not focusing their efforts.
The Foundation's Michael Jon Barlin Pediatric Research Program, the only one of its kind in the nation, has a dedicated focus on pediatric lupus research. This program is dedicated to research that will facilitate the care of children with lupus.
Past and present areas of research focus include: cardiovascular; skin; kidney; neuropsychiatric disease manifestations of lupus; the genetics of pediatric, adolescent, and male lupus; fatigue; mid-to-late stage translational research; adult stem cell transplantation; animal models of lupus; identification and validation of biomarkers; patient-reported outcomes and improved early recognition and diagnosis of lupus.
We also offers student fellowships through the Gina M. Finzi Memorial Student Summer Fellowship program.
We are leading the fight to end lupus and are committed to accelerating the pace of medical discoveries relevant to lupus, with the clear goal of making clinical research more feasible. Our goal is to speed development and approval of new, tolerable and effective treatments for lupus to improve the quality of life for those who are living with this mysterious and devastating disease.
Leveraging Donor Support
Our research program is funded by individuals and institutions, which include corporations (family and health-related) and foundations, and our nationwide network of chapters, field offices, support groups and community representatives who support the national research program. Learn about how you can sponsor a lupus project here.